drugset / Trial / NCT06485505

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

NCT06485505

Phase 1 Recruiting 36 enrolled Zagazig University
RandomizedParallel-groupSingle-blindTreatment

Summary

3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.

Timeline

Start
2024-07-12
Primary completion
2026-07
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Isotretinoin Other / unclassified 10 mg
Subject Isotretinoin Other / unclassified 20 mg
Comparator Itraconazole Small molecule 200 mg

Indications